SCHEMBL24920787

SCHEMBL24920787

COc1ccnc(-c2nnco2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
NOTUM Q6P988 10/20 0.42
MAPT P10636 3/20 0.41
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TLR8 Q9NR97 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14031860 0.78 HPGDS (0.38) PIM1PIM2NPC1CYP1A2CYP3A4
SCHEMBL24921789 0.77 NPC1 (0.38) ALDH1A1HPGDMAPK1NOTUMMAPT
SCHEMBL24921240 0.74 ALDH1A1 (0.58) ALDH1A1HPGDMAPK1NOTUMMAPT
SCHEMBL25986827 0.74 NOTUM (0.39) ALDH1A1HPGDMAPK1NOTUMMAPT
SCHEMBL25693366 0.74 NOTUM (0.46) ALDH1A1HPGDMAPK1NOTUMMAPT
SCHEMBL25986910 0.74 NOTUM (0.39) ALDH1A1HPGDMAPK1NOTUMMAPT
SCHEMBL24920778 0.74 PIM1 (0.39) PIM1PIM2NPC1RAB9ACYP1A2
SCHEMBL24921992 0.73 MAPT (0.42) ALDH1A1HPGDMAPK1NOTUMMAPT
SCHEMBL5426257 0.73 NOTUM (0.39) ALDH1A1NOTUMMAPTPIM1PIM2
SCHEMBL24920803 0.72 S1PR1 (0.35) HPGDPIM1PIM2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed